Merit Medical Systems Long Term Debt 2012-2026 | MMSI

Merit Medical Systems long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
  • Merit Medical Systems long term debt for the quarter ending June 30, 2026 was $0.736B, a 0.61% increase year-over-year.
  • Merit Medical Systems long term debt for 2025 was $0.734B, a 0.62% increase from 2024.
  • Merit Medical Systems long term debt for 2024 was $0.73B, a 11.36% decline from 2023.
  • Merit Medical Systems long term debt for 2023 was $0.823B, a 340.68% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Merit Medical Systems Annual Long Term Debt
(Millions of US $)
2025 $734
2024 $730
2023 $823
2022 $187
2021 $234
2020 $344
2019 $432
2018 $373
2017 $259
2016 $314
2015 $198
2014 $214
2013 $239
2012 $228
2011 $31
Merit Medical Systems Quarterly Long Term Debt
(Millions of US $)
2026-06-30 $736
2026-03-31 $735
2025-12-31 $734
2025-09-30 $733
2025-06-30 $732
2025-03-31 $731
2024-12-31 $730
2024-09-30 $751
2024-06-30 $801
2024-03-31 $800
2023-12-31 $823
2023-09-30 $282
2023-06-30 $335
2023-03-31 $186
2022-12-31 $187
2022-09-30 $205
2022-06-30 $236
2022-03-31 $243
2021-12-31 $234
2021-09-30 $271
2021-06-30 $285
2021-03-31 $313
2020-12-31 $344
2020-09-30 $350
2020-06-30 $403
2020-03-31 $438
2019-12-31 $432
2019-09-30 $432
2019-06-30 $385
2019-03-31 $362
2018-12-31 $373
2018-09-30 $187
2018-06-30 $392
2018-03-31 $366
2017-12-31 $259
2017-09-30 $261
2017-06-30 $225
2017-03-31 $220
2016-12-31 $314
2016-09-30 $318
2016-06-30 $222
2016-03-31 $218
2015-12-31 $198
2015-09-30 $200
2015-06-30 $200
2015-03-31 $203
2014-12-31 $214
2014-09-30 $230
2014-06-30 $238
2014-03-31 $244
2013-12-31 $239
2013-09-30 $241
2013-06-30 $247
2013-03-31 $244
2012-12-31 $228
2012-09-30 $65
2012-06-30 $57
2012-03-31 $53
2011-12-31 $31
2011-09-30 $6
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.146B $1.516B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $104.880B 22.04
Cardinal Health (CAH) United States $54.109B 20.66
Becton Dickinson (BDX) United States $51.228B 14.30
West Pharmaceutical Services (WST) United States $25.687B 42.94
Straumann Holding AG (SAUHY) Switzerland $18.592B 0.00
Align Technology (ALGN) United States $10.528B 16.28
Cooper (COO) United States $10.130B 11.56
Henry Schein (HSIC) United States $9.754B 16.48
DENTSPLY SIRONA (XRAY) United States $1.960B 6.87
CONMED (CNMD) United States $1.406B 9.82
STAAR Surgical (STAA) United States $1.125B 35.07
Pro-Dex (PDEX) United States $0.214B 19.97
Lifevantage (LFVN) United States $0.077B 11.04